These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 22215742

  • 1. Delivery of large heterologous polypeptides across the cytoplasmic membrane of antigen-presenting cells by the Bordetella RTX hemolysin moiety lacking the adenylyl cyclase domain.
    Holubova J, Kamanova J, Jelinek J, Tomala J, Masin J, Kosova M, Stanek O, Bumba L, Michalek J, Kovar M, Sebo P.
    Infect Immun; 2012 Mar; 80(3):1181-92. PubMed ID: 22215742
    [Abstract] [Full Text] [Related]

  • 2. Cyclic AMP-Elevating Capacity of Adenylate Cyclase Toxin-Hemolysin Is Sufficient for Lung Infection but Not for Full Virulence of Bordetella pertussis.
    Skopova K, Tomalova B, Kanchev I, Rossmann P, Svedova M, Adkins I, Bibova I, Tomala J, Masin J, Guiso N, Osicka R, Sedlacek R, Kovar M, Sebo P.
    Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28396322
    [Abstract] [Full Text] [Related]

  • 3. Third activity of Bordetella adenylate cyclase (AC) toxin-hemolysin. Membrane translocation of AC domain polypeptide promotes calcium influx into CD11b+ monocytes independently of the catalytic and hemolytic activities.
    Fiser R, Masín J, Basler M, Krusek J, Spuláková V, Konopásek I, Sebo P.
    J Biol Chem; 2007 Feb 02; 282(5):2808-20. PubMed ID: 17148436
    [Abstract] [Full Text] [Related]

  • 4. Pore-formation by adenylate cyclase toxoid activates dendritic cells to prime CD8+ and CD4+ T cells.
    Svedova M, Masin J, Fiser R, Cerny O, Tomala J, Freudenberg M, Tuckova L, Kovar M, Dadaglio G, Adkins I, Sebo P.
    Immunol Cell Biol; 2016 Apr 02; 94(4):322-33. PubMed ID: 26437769
    [Abstract] [Full Text] [Related]

  • 5. Retargeting from the CR3 to the LFA-1 receptor uncovers the adenylyl cyclase enzyme-translocating segment of Bordetella adenylate cyclase toxin.
    Masin J, Osickova A, Jurnecka D, Klimova N, Khaliq H, Sebo P, Osicka R.
    J Biol Chem; 2020 Jul 10; 295(28):9349-9365. PubMed ID: 32393579
    [Abstract] [Full Text] [Related]

  • 6. Bordetella adenylate cyclase toxin: a unique combination of a pore-forming moiety with a cell-invading adenylate cyclase enzyme.
    Masin J, Osicka R, Bumba L, Sebo P.
    Pathog Dis; 2015 Nov 10; 73(8):ftv075. PubMed ID: 26391732
    [Abstract] [Full Text] [Related]

  • 7. Adenylate cyclase toxin translocates across target cell membrane without forming a pore.
    Osickova A, Masin J, Fayolle C, Krusek J, Basler M, Pospisilova E, Leclerc C, Osicka R, Sebo P.
    Mol Microbiol; 2010 Mar 10; 75(6):1550-62. PubMed ID: 20199594
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Charge-dependent translocation of Bordetella pertussis adenylate cyclase toxin into eukaryotic cells: implication for the in vivo delivery of CD8(+) T cell epitopes into antigen-presenting cells.
    Karimova G, Fayolle C, Gmira S, Ullmann A, Leclerc C, Ladant D.
    Proc Natl Acad Sci U S A; 1998 Oct 13; 95(21):12532-7. PubMed ID: 9770520
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming.
    Schlecht G, Loucka J, Najar H, Sebo P, Leclerc C.
    J Immunol; 2004 Nov 15; 173(10):6089-97. PubMed ID: 15528345
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bioengineering of Bordetella pertussis Adenylate Cyclase Toxin for Antigen-Delivery and Immunotherapy.
    Chenal A, Ladant D.
    Toxins (Basel); 2018 Jul 20; 10(7):. PubMed ID: 30037010
    [Abstract] [Full Text] [Related]

  • 14. Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity.
    Fayolle C, Osickova A, Osicka R, Henry T, Rojas MJ, Saron MF, Sebo P, Leclerc C.
    J Virol; 2001 Aug 20; 75(16):7330-8. PubMed ID: 11462005
    [Abstract] [Full Text] [Related]

  • 15. Bordetella adenylate cyclase toxin mobilizes its beta2 integrin receptor into lipid rafts to accomplish translocation across target cell membrane in two steps.
    Bumba L, Masin J, Fiser R, Sebo P.
    PLoS Pathog; 2010 May 13; 6(5):e1000901. PubMed ID: 20485565
    [Abstract] [Full Text] [Related]

  • 16. Transmembrane segments of complement receptor 3 do not participate in cytotoxic activities but determine receptor structure required for action of Bordetella adenylate cyclase toxin.
    Wald T, Osickova A, Masin J, Liskova PM, Petry-Podgorska I, Matousek T, Sebo P, Osicka R.
    Pathog Dis; 2016 Apr 13; 74(3):. PubMed ID: 26802078
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Negatively charged residues of the segment linking the enzyme and cytolysin moieties restrict the membrane-permeabilizing capacity of adenylate cyclase toxin.
    Masin J, Osickova A, Sukova A, Fiser R, Halada P, Bumba L, Linhartova I, Osicka R, Sebo P.
    Sci Rep; 2016 Sep 01; 6():29137. PubMed ID: 27581058
    [Abstract] [Full Text] [Related]

  • 19. Selective Enhancement of the Cell-Permeabilizing Activity of Adenylate Cyclase Toxin Does Not Increase Virulence of Bordetella pertussis.
    Holubova J, Juhasz A, Masin J, Stanek O, Jurnecka D, Osickova A, Sebo P, Osicka R.
    Int J Mol Sci; 2021 Oct 28; 22(21):. PubMed ID: 34769101
    [Abstract] [Full Text] [Related]

  • 20. Pore-forming and enzymatic activities of Bordetella pertussis adenylate cyclase toxin synergize in promoting lysis of monocytes.
    Basler M, Masin J, Osicka R, Sebo P.
    Infect Immun; 2006 Apr 28; 74(4):2207-14. PubMed ID: 16552051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.